Clinical Trials on Advanced HCC

Total 6370 results

Bristol-Myers Squibb

Completed

A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors

Advanced Cancer

China
Case Comprehensive Cancer Center

Completed

Online Information and Support for Distance Caregivers

Advanced Cancer

United States
Bristol-Myers Squibb

Completed

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Advanced Cancer

United States, Canada, Italy, Netherlands, Spain, Israel
Five Prime Therapeutics, Inc.
Parexel

Completed

Safety Study of FP-1039 To Treat Cancer

Advanced Cancer

United States
BeiGene

Completed

Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors

Advanced Cancer

United States, Taiwan, Australia, Korea, Republic of, New Zealand
Bristol-Myers Squibb

Completed

An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors

Advanced Cancer

United States, Belgium, Canada
Bristol-Myers Squibb

Completed

Phase 1 Study of Mesothelin-ADC

Advanced Cancer

Japan
Royal Marsden NHS Foundation Trust
AstraZeneca; Institute of Cancer Research, United Kingdom

Completed

Trial of Olaparib in Combination With AZD5363 (ComPAKT) (ComPAKT)

Advanced Cancer

United Kingdom
M.D. Anderson Cancer Center

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Advanced Cancers

United States
Eli Lilly and Company

Completed

C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors

Advanced Cancer

Switzerland
Seoul National University Hospital
Asan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Ewha Womans University Mokdong Hospital and other collaborators

Completed

Efficacy of Self-education Program for Advanced Care Planning(RCT)

Advanced Cancer

Korea, Republic of
Celldex Therapeutics

Completed

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors

Advanced Cancer

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)

Cancer, Advanced
M.D. Anderson Cancer Center

Completed

Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials

Advanced Cancer

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Sinotecean on Tolerance and Pharmacokinetics

Advanced Cancer

China
M.D. Anderson Cancer Center
Gateway for Cancer Research; Theravalues, Inc.

Completed

Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)

Advanced Cancers

United States
Shenyang Pharmaceutical University

Unknown

Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients

Advanced Cancer

China
Duke University
National Cancer Institute (NCI)

Completed

Intervention Study of Communication in Oncologist-Patient Encounters (COPE)

Advanced Cancer

United States
M.D. Anderson Cancer Center
GE Healthcare

Withdrawn

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Advanced Cancers
M.D. Anderson Cancer Center

Completed

Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study

Advanced Cancers

United States
Alaunos Therapeutics

Completed

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

The Role of the EKG in Anticancer Drug Development

Advanced Cancer

United States
Alaunos Therapeutics

Completed

Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

Advanced Cancer

United States
AstraZeneca

Completed

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

Advanced Tumor

Netherlands
Alaunos Therapeutics

Suspended

Study of Oral Palifosfamide Tris in Solid Tumors

Advanced Cancer
University of Cincinnati

Not yet recruiting

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Cancer | Metastatic Cancer | Locally Advanced Solid Tumor | Locally Advanced | Locally Advanced Carcinoma

United States
Codiak BioSciences

Terminated

A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)

Advanced Hepatocellular Carcinoma (HCC) | Gastric Cancer Metastatic to Liver | Colorectal Cancer Metastatic to Liver

United States
Alexandria University

Completed

Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

hCG | FET | Frozen-thawed Embryo Transfe | Human Chorionic Gonadotrophin

Egypt
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
University of California, San Francisco

Completed

Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer

Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
Eisai Co., Ltd.

Completed

Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)

Unresectable Hepatocellular Carcinoma (HCC)

China
Amgen

Completed

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology Patients

United States
Kyowa Kirin, Inc.
Bristol-Myers Squibb

Completed

Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors

Carcinoma | HCC | Cancer | Hepatocellular Carcinoma | Solid Tumor

United States
Assiut University

Unknown

Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases (RAVs)

HCV
Assistance Publique Hopitaux De Marseille

Unknown

Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients (HCURE)

HIV Associated HCV

France
Shanghai Miracogen Inc.

Recruiting

A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer

Advanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction Cancer

United States
Zhongda Hospital

Not yet recruiting

Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study (CHANCE023)

HCC
Peking University Cancer Hospital & Institute

Completed

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

HCC

China
Lahey Clinic
Varian Medical Systems; Merit Medical Systems, Inc.

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant (SBRTvsTACE)

HCC | Hepatocellular Carcinoma

United States, Canada
Stephen Chan Lam

Active, not recruiting

Cabozantinib in Hepatocellular Carcinoma

HCC

Korea, Republic of, Hong Kong
Icahn School of Medicine at Mount Sinai

Completed

Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)

HCC | Hepatocellular Carcinoma

United States
Terumo Europe N.V.
Federation Francophone de Cancerologie Digestive; Fundacion Clinic per a la...

Completed

LifePearl-Doxo Pharmacokinetic (PK) Study

HCC | Hepatocellular Carcinoma

Switzerland, Spain, Greece
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients (PREVENT-HCV)

HCV

United States
Reproductive Medicine Associates of New Jersey

Completed

Intrauterine Human Chorionic Gonadotropin at the Time of Embryo Transfer

Control Media Only | Study hCG and Media

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

HCV
Pulse Biosciences, Inc.

Completed

CellFX Treat & Resect Low-Risk BCC Feasibility Study

BCC | BCC - Basal Cell Carcinoma | Excision Margin

United States
Humanitas Clinical and Research Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Federico II University and other collaborators

Active, not recruiting

Artificial Intelligence and Hepatocellular Carcinoma (ARTIHCC)

HCC

Italy
Meridian Bioscience, Inc.

Completed

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Hepatocellular Carcinoma (HCC)

China
Novartis Pharmaceuticals

Completed

FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression

Hepatocellular Carcinoma (HCC) | Solid Malignancies

United States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
National Taiwan University Hospital

Completed

Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI

Hepatocellular Carcinoma (HCC)

Taiwan

Clinical Trials on Advanced HCC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations